论文部分内容阅读
目的了解医院糖尿病神经病变药物的使用情况,为临床合理用药提供参考依据。方法调查2015年医院217例糖尿病神经病变患者的住院情况及用药记录,并进行统计分析。结果 217例糖尿病神经病变患者中,治疗糖尿病神经病变药物使用27个品种,其中排列前5位的是依帕司他、硫辛酸、丹参酮ⅡA磺酸钠、甲钴胺注射液、长春西汀;在对患者的治疗方案中,8例单独用药,其余均为联合用药,药物的用法、用量和疗程大部分都符合药品说明书所规定的用法用量,所有病例中,未有不良反应报告。结论 217例糖尿病神经病变患者的药物治疗基本合理,但在药物使用的疗程、联合用药,特别是中药制剂的联合应用中仍存在不合理之处,需进一步规范。
Objective To understand the use of diabetic neuropathy in hospitals and provide a reference for clinical rational use of drugs. Methods 217 hospitalized patients with diabetic neuropathy in 2015 were surveyed for hospitalization and medication records, and statistical analysis was performed. Results Among the 217 patients with diabetic neuropathy, 27 varieties were used in the treatment of diabetic neuropathy. Among them, the top 5 were epalrestat, lipoic acid, tanshinone Ⅱ A sulfonate, mecobalamin injection and vinpocetine. In the treatment of patients, 8 patients were treated alone, the rest are combined medication, drug usage, dosage and course of treatment are in line with the drug specification prescribed dosage usage, in all cases, no adverse reaction. Conclusion 217 cases of diabetic neuropathy patients with basic reasonable medication, but in the course of drug use, combination, especially the combination of traditional Chinese medicine preparations still exist unreasonable, need further specification.